icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
Back grey_arrow_rt.gif
 
 
 
Disease Progression Among Commercially Insured Patients Infected With Hepatitis Delta Virus in the United States
 
 
 
AASLD 2025 Nov 7-11 Wash DC
 
Robert G Gish1,2, Robert J Wong3, Chong Kim4, Gary Leung5, Ira M Jacobson6, Joseph K Lim7, Marvin Rock4 1Robert G. Gish Consultants, LLC, San Diego, CA, USA; 2Hepatitis B Foundation, Doylestown, PA, USA; 3Stanford University School of Medicine, Stanford, CA, USA; 4HEOR-Global Value & Access, Gilead Sciences, Inc., Foster City, CA, USA; 5RWE-Epidemiology, Gilead Sciences, Inc., Foster City, CA, USA; 6NYU Grossman School of Medicine, New York, NY, USA; 7Yale University School of Medicine, New Haven, CT, USA

1112251

1112252

1112253

1112254

1112255

1112256

1112257

1112258